IgG Glyco-Engineering to Improve IVIg Potency

Intravenous immunoglobulins (IVIg) are used in the treatment of different autoimmune and inflammatory diseases, such as immune thrombocytopenia and hemolytic anemia. One of the modes of action of IVIg is preventing phagocytosis of autoantibody-opsonized blood cells by saturation of the Fc-gamma rece...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Bruggeman, Christine W., Dekkers, Gillian, Visser, Remco, Goes, Naneth W. M., van den Berg, Timo K., Rispens, Theo, Vidarsson, Gestur, Kuijpers, Taco W.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206079/
https://ncbi.nlm.nih.gov/pubmed/30405631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02442
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars